Montauk Metals Inc
MTK
Eguana Technologies Inc
EGT
Blueberries Medical Corp
BBM
Aquarius Surgical Technologies Inc
ASTI
Akita Drilling Ltd
AKT.B
(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -163.67%-97.32K | 146.62%179.24K | 28.88%-120.36K | -545.77%-214.31K | 672.00%186.55K | 64.85%152.85K | -158.16%-384.46K | -14,630.20%-169.25K | 92.49%-33.19K | 24.14%24.17K |
Net income from continuing operations | 50.30%-55.84K | -84.76%71.91K | 139.93%70.91K | 87.75%-100.63K | 40.05%-282.45K | -476.75%-112.36K | 276.31%471.77K | -181.09%-177.59K | -268.26%-821.41K | -3,269.00%-471.17K |
Operating gains losses | -38.29%64.58K | 116.70%98.04K | -152.91%-10.08K | -198.59%-249.9K | 27.06%213.37K | --104.66K | ---586.98K | --19.05K | 124.26%253.49K | 1,626.65%167.93K |
Depreciation and amortization | -30.28%40.93K | 28.14%74.99K | -91.76%4.82K | -2.36%235.07K | -5.28%59.39K | -1.62%58.71K | -1.77%58.52K | -0.58%58.46K | 0.91%240.76K | -2.81%62.7K |
Unrealized gains and losses of investment securities | -51.59%22.45K | -188.49%-176.22K | -170.86%-23.19K | -36.76%162.88K | -151.21%-115.37K | 9,761.46%46.38K | -9.71%199.15K | -60.77%32.73K | 399.53%257.58K | ---45.93K |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 257.64%298.54K | 395.29%270K |
Other non cashItems | -4.69%2.95K | -4.69%2.95K | -4.69%2.95K | -46.69%10.65K | -55.61%1.37K | 0.00%3.09K | -55.24%3.09K | -55.09%3.09K | -28.78%19.98K | -55.25%3.09K |
Change In working capital | -429.17%-172.39K | 120.30%107.58K | -57.89%-165.77K | 3.45%-272.38K | 726.56%310.25K | 246.92%52.37K | -214.73%-530.01K | 9.18%-104.99K | -88.78%-282.12K | 254.19%37.54K |
-Change in receivables | -64.88%-56.74K | 126.24%94.49K | -388.53%-108.89K | -360.38%-65.54K | 4,737.00%291.28K | -136.46%-34.41K | -303.66%-360.15K | 169.89%37.74K | -12.76%25.17K | 134.16%6.02K |
-Change in inventory | -98.40%2.26K | 93.63%-3.85K | 137.56%29.46K | -16,648.32%-24.96K | -1,625.62%-27.51K | 5,185.36%141.37K | -1,066.61%-60.39K | -1,346.99%-78.43K | -100.72%-149 | -17.71%1.8K |
-Change in prepaid assets | -86.32%10.9K | 169.23%36K | -55.52%-43.37K | -394.80%-28.76K | -551.30%-28.52K | 2,773.65%79.65K | -892.35%-52K | -77.43%-27.89K | -152.77%-5.81K | -94.79%6.32K |
-Change in payables and accrued expense | 4.04%-128.81K | 66.83%-19.06K | -18.00%-42.97K | 49.18%-153.12K | 220.62%74.99K | -8.02%-134.24K | 37.54%-57.46K | 66.42%-36.42K | -43.47%-301.33K | 117.95%23.39K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -163.67%-97.32K | 146.62%179.24K | 28.88%-120.36K | -545.77%-214.31K | 672.00%186.55K | 64.85%152.85K | -158.16%-384.46K | -14,630.20%-169.25K | 92.49%-33.19K | 24.14%24.17K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 294.76%10.57K | -101.15%-3.89K | -106.52%-4.12K | 642.58%261.76K | -1,283.05%-133.59K | -104.24%-5.43K | 1,225.86%337.58K | 185.32%63.19K | -79.10%35.25K | 119.95%11.29K |
Net PPE purchase and sale | -650.47%-40.71K | -101.65%-3.89K | 58.28%-4.12K | 144.39%86.79K | -50.74%-133.59K | -90.89%-5.43K | 886.03%235.68K | 86.66%-9.88K | -129.99%-195.51K | -56.53%-88.62K |
Net investment purchase and sale | --51.28K | --0 | --0 | -24.18%174.97K | --0 | --0 | --101.9K | --73.08K | --230.76K | --99.91K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 294.76%10.57K | -101.15%-3.89K | -106.52%-4.12K | 642.58%261.76K | -1,283.05%-133.59K | -104.24%-5.43K | 1,225.86%337.58K | 185.32%63.19K | -79.10%35.25K | 119.95%11.29K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 1,773.26%68.09K | -79.75%46.92K | -79.24%18.35K | 0 | -16.38%24.94K | -97.32%3.64K | -41.24%231.66K | -31.06%88.39K |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---146.93K | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | 1,700.00%68.4K | -87.17%48.8K | -77.52%20K | --0 | -16.67%25K | -97.49%3.8K | 157.83%380.3K | 789.50%88.95K |
Net other financing activities | --0 | --0 | -86.06%-307 | -9.56%-1.88K | -194.64%-1.65K | --0 | 63.89%-65 | 74.02%-165 | 47.68%-1.72K | 97.91%-560 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | 1,773.26%68.09K | -79.75%46.92K | -79.24%18.35K | --0 | -16.38%24.94K | -97.32%3.64K | -41.24%231.66K | -31.06%88.39K |
Net cash flow | ||||||||||
Beginning cash position | 31.05%261.37K | -23.37%169.64K | -33.31%215.96K | 90.52%323.81K | -13.45%242.21K | 146.02%199.45K | -3.81%221.39K | 90.52%323.81K | 247.93%169.96K | 254.74%279.83K |
Current changes in cash | -158.84%-86.75K | 899.16%175.35K | 44.94%-56.39K | -59.62%94.37K | -42.42%71.31K | -25.83%147.42K | 85.28%-21.94K | -270.14%-102.42K | 92.99%233.72K | 35.99%123.85K |
Effect of exchange rate changes | 86.04%-14.61K | ---83.63K | --10.08K | -153.19%-202.23K | ---97.57K | ---104.66K | --0 | --0 | ---79.87K | ---- |
End cash Position | -33.94%160.01K | 31.05%261.37K | -23.37%169.64K | -33.31%215.96K | -33.31%215.96K | -13.45%242.21K | 146.02%199.45K | -3.81%221.39K | 90.52%323.81K | 90.52%323.81K |
Free cash from | -193.63%-138.03K | 145.33%175.35K | 30.51%-124.49K | -10.32%-252.29K | 357.92%166.24K | 64.02%147.42K | -116.21%-386.82K | -138.17%-179.13K | 56.59%-228.7K | -73.51%-64.46K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.